Pharmacokinetics of baricitinib in critically ill COVID-19 patients
Description
CONCLUSION: High inter-patient variability and relatively low baricitinib trough concentrations and AUC were observed in critically ill COVID-19 patients receiving the usual dosage of 4 mg/day. This preliminary study encourages further exploration of
